# For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

Study · id `cardio:ct-nct05068349` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05068349](<https://clinicaltrials.gov/study/NCT05068349>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05068349

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT05068349. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-07 (actual); primary completion 2025-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT05068349, source copy `cardio:ctgov-nct05068349-2024-04-09`, retrieved 2026-10-26)
- Started: 2022-05-07 (actual) (ClinicalTrials.gov record NCT05068349, source copy `cardio:ctgov-nct05068349-2024-04-09`, retrieved 2026-10-26)
- Primary completion: 2025-09 (anticipated) (ClinicalTrials.gov record NCT05068349, source copy `cardio:ctgov-nct05068349-2024-04-09`, retrieved 2026-10-26)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT05068349, source copy `cardio:ctgov-nct05068349-2024-04-09`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05068349, source copy `cardio:ctgov-nct05068349-2024-04-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05068349-2024-04-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
- Condition: Stroke
- Condition: Cerebral Infarction
- Condition: Brain Infarction
- Condition: Brain Ischemia
- Condition: Nervous System Diseases
- Condition: Central Nervous System Diseases
- Condition: Vascular Diseases
- Intervention (Drug): Butylphthalide
- Lead sponsor: Qianfoshan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Qianfoshan Hospital (`cardio:org-qianfoshan-hospital`)

## Provenance

Content hash: 59b83b692368887e503cfd50b4ca917ebb2fe828cd473bf0816cd916298d528e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
